Univariate Analysis of Prognostic Factors for Survival
| . | N . | Median Survival (months) . | % Survival at 4 Years . | P . |
|---|---|---|---|---|
| Age | ||||
| ≤40 >40 | 44 12 | 36 14 | 43 ± 15 33 ± 27 | .67 |
| Relapse | ||||
| Nodal Extranodal | 28 28 | NR 12 | 55 ± 20 26 ± 17 | .005 |
| B symptoms | ||||
| Y N | 21 35 | 12 NR | 23 ± 18 51 ± 18 | .008 |
| Duration 1st remission | ||||
| <12 mo ≥12 mo | 33 23 | 25 31 | 40 ± 12 41 ± 21 | .74 |
| Stage at relapse | ||||
| Localized Disseminated | 19 37 | NR 15 | 55 ± 24 34 ± 16 | .06 |
| . | N . | Median Survival (months) . | % Survival at 4 Years . | P . |
|---|---|---|---|---|
| Age | ||||
| ≤40 >40 | 44 12 | 36 14 | 43 ± 15 33 ± 27 | .67 |
| Relapse | ||||
| Nodal Extranodal | 28 28 | NR 12 | 55 ± 20 26 ± 17 | .005 |
| B symptoms | ||||
| Y N | 21 35 | 12 NR | 23 ± 18 51 ± 18 | .008 |
| Duration 1st remission | ||||
| <12 mo ≥12 mo | 33 23 | 25 31 | 40 ± 12 41 ± 21 | .74 |
| Stage at relapse | ||||
| Localized Disseminated | 19 37 | NR 15 | 55 ± 24 34 ± 16 | .06 |